Neuropeptide Y and reserpine‐resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle
暂无分享,去创建一个
[1] T. Kahan,et al. Prejunctional beta 2-adrenoreceptor blockade reduces nerve stimulation evoked release of endogenous noradrenaline in skeletal muscle in situ. , 1987, Acta physiologica Scandinavica.
[2] G. Fried,et al. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen. , 1987, Acta physiologica Scandinavica.
[3] I. Muramatsu. The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study , 1987, British Journal of Pharmacology.
[4] L. Kaijser,et al. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. , 1987, Life sciences.
[5] G. Burnstock,et al. A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation , 1987, British journal of pharmacology.
[6] J. Kelly,et al. Effect of reserpine, phenoxybenzamine and cold stress on the neuropeptide Y content of the rat peripheral nervous system , 1986, Neuroscience.
[7] E Theodorsson-Norheim,et al. Kruskal-Wallis test: BASIC computer program to perform nonparametric one-way analysis of variance and multiple comparisons on ranks of several independent samples. , 1986, Computer methods and programs in biomedicine.
[8] A. Sollevi,et al. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen , 1986, Neuroscience Letters.
[9] A. Franco‐Cereceda,et al. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. , 1985, Acta physiologica Scandinavica.
[10] J. Lundberg,et al. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. , 1985, Scandinavian journal of clinical and laboratory investigation.
[11] P. Hjemdahl,et al. Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle. , 1984, Acta physiologica Scandinavica.
[12] J. Pernow,et al. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation , 1984, Neuroscience Letters.
[13] G. Burnstock,et al. ATP as a co-transmitter in rat tail artery. , 1984, European journal of pharmacology.
[14] C. Wahlestedt,et al. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers , 1984, Regulatory Peptides.
[15] T. Hökfelt,et al. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man , 1983, Neuroscience Letters.
[16] B. Fredholm,et al. Influence of adenosine on the vascular responses to sympathetic nerve stimulation in the canine subcutaneous adipose tissue. , 1983, Acta physiologica Scandinavica.
[17] T. Neild,et al. Noradrenergic neuromuscular transmission with special reference to arterial smooth muscle , 1982, Progress in Neurobiology.
[18] T. Hökfelt,et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.
[19] J. Lundberg,et al. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. , 1982, Acta physiologica Scandinavica.
[20] K. Tatemoto. Neuropeptide Y: complete amino acid sequence of the brain peptide. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Hirst,et al. Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle , 1980, Nature.
[22] P. Hjemdahl,et al. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.
[23] B. Wallin,et al. The variability of muscle nerve sympathetic activity in resting recumbent man , 1977, The Journal of physiology.
[24] B. Fredholm. Release of adenosine-like material from isolated perfused dog adipose tissue following sympathetic nerve stimulation and its inhibition by adrenergic alpha-receptor blockade. , 1976, Acta physiologica Scandinavica.
[25] J. Thorson,et al. Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline. , 1965, Acta physiologica Scandinavica.
[26] G. Sedvall,et al. The rate of disappearance of vasoconstrictor responses to sympathetic chain stimulation after reserpine treatment. , 1962, Acta physiologica Scandinavica.
[27] J. Axelrod,et al. Effect of decentralization and ganglionic blocking agents on the spontaneous release of H3-norepinephrine. , 1962, The Journal of pharmacology and experimental therapeutics.
[28] S. Rosell,et al. The influence of sympathetic adrenergic vasoconstrictor nerves on transport of diffusible solutes from blood to tissues in skeletal muscle. , 1962, Acta physiologica Scandinavica.
[29] R. Sidman,et al. Effect of Reserpine on Noradrenaline Content of Innervated and Denervated Brown Adipose Tissue of the Rat , 1962, Nature.
[30] B. Folkow. Impulse frequency in sympathetic vasomotor fibres correlated to the release and elimination of the transmitter. , 1952, Acta physiologica Scandinavica.
[31] P. Hjemdahl,et al. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. , 1988, Acta physiologica Scandinavica.
[32] P. Hjemdahl. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. , 1987, Methods in enzymology.
[33] P. Hjemdahl. [63] Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection , 1987 .
[34] G. Fried,et al. NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? , 1986, Acta physiologica Scandinavica.
[35] T. Hökfelt,et al. Neuropeptide Y and noradrenaline interaction in peripheral cardiovascular control. , 1984, Clinical and experimental hypertension. Part A, Theory and practice.
[36] A. Carlsson. Drugs which block the storage of 5-hydroxytryptamine and related amines , 1966 .
[37] T. Grahame,et al. Topographical Anatomy of the Dog , 1943, Nature.